ERA PerMed - Multidisciplinary Research Projects on Personalised Medicine – Pre-/Clinical research, Big Data and ICT, Implementation and User’s Perspective

The ERA PerMed Multidisciplinary Research Projects on Personalised Medicine – Pre-/Clinical research, Big Data and ICT, Implementation and User’s Perspective launched a call for proposals with pre-Proposal deadline March 5, 2020.

Deadline:

Pre-Proposal: 05 March 2020, 17:00 CET

Full-Proposal: 15 June 2020, 17:00 CET

Publication Date:

23 December 2019

Weblink (URL):

http://www.erapermed.eu/joint-calls/joint-transnational-call-2020/

Short Call Abstract:

With its third transnational call (non-cofunded by the EC), ERA PerMed fosters research and innovation activities that build close linkages between basic biomedical research, clinical research, physical sciences, bioengineering, bioinformatics and biostatistics, epidemiology, socio-economic research, as well as research on the integration of PM into clinical practice and on ethical, legal and social implications across the participating countries and beyond. This implies a wide range of multidisciplinary activities brought together by different stakeholders from academia (e.g. universities and research institutions), clinics (e.g. clinical laboratories, medical professionals), industry (e.g. pharmaceutical industry, biotechnology companies, information technology companies including health information technology – HIT), policy makers, regulatory/health technology assessment (HTA) agencies and patients/patient organisations.

Moreover, proposals are expected to include research on ethical, legal and socio-economic implications, including health economics and regulation, and/or research on the optimisation of health care systems. They may also consider patient and citizen empowerment and training strategies for the different stakeholders in PM.

SSH aspects (keywords/disciplines):

Economics, sociology, ethics

Specific participation requirements (optional):

Joint research proposals may be submitted by applicants belonging to one of the following, if eligible according to their respective regional/national funding organisation’s regulations for research funding:

  • Academia (research teams working in universities, other higher education institutions) or research institutes;
  • Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of clinicians (e.g. medical doctors, nurses) in the research teams is encouraged;
  • (Industry) Private partners, e.g. SMEs (small and medium-size enterprises).